# TRIO (NCT03978663)

> Three Fraction Radiation to Induce Immuno-Oncologic Response

No report yet. It can be ordered.

## Registry

- Registry record: https://clinicaltrials.gov/study/NCT03978663
- Phase: NA
- Status: ACTIVE_NOT_RECRUITING
- Sponsor: London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
- Conditions: High-Risk Cancer; Locally Advanced Breast Cancer
- Interventions: Neoadjuvant radiotherapy
- Enrollment: 40
- Primary outcome: Pathologic complete response

## Commentary we found

- Podcasts: 3
- YouTube: 2
- X threads: 2

## Order

Focused, $750, price fixed at order: https://www.erudio.com/contact?report=trio-nct03978663